urine diagnostics

A new study in Nature reports that cell-free RNA found in urine can be used to detect bladder cancer and predict how patients respond to treatment. The liquid biopsy approach could offer a non-invasive alternative to cystoscopy, potentially enabling earlier diagnosis and closer monitoring of therapy response without invasive procedures.

A new RNA-based urine test for bladder cancer has reportedly outperformed standard diagnostic tests and may help guide treatment decisions. The test detects molecular markers in urine, offering a non-invasive alternative to invasive procedures. Commenters shared the news enthusiastically, with some joking about the simplicity of providing a sample. The development is being welcomed as a potential step forward in earlier detection and personalized care.

Researchers at Stanford Medicine report that a urine test could improve how bladder cancer is diagnosed and help guide treatment decisions. The non-invasive approach may allow doctors to detect the disease and tailor care without more invasive procedures. The announcement is drawing attention as a potential step forward in cancer diagnostics.

A urine-based RNA test could detect bladder cancer and predict how patients respond to treatment, according to a report from Inside Precision Medicine. If validated, the non-invasive test would offer an alternative to invasive procedures such as cystoscopy and help doctors tailor therapies to individual patients. The finding is drawing attention among clinicians and researchers focused on earlier, less burdensome cancer diagnostics.